Allergy is described as an abnormal or pathologic immune reaction that occurs in response to foreign material. The foreign material include pollen, dust mites, mold spores, pet dander, food, medicine and many more. Allergies can cause a variety of symptoms such as runny nose, sneezing, rashes, swelling, or itching. Symptoms can range from minor to severe. Allergies includes food allergy, allergic asthma, atopic dermatitis, allergic rhinitis, hay fever, and anaphylaxis. Anaphylaxis is a severe and life-threatening reaction that requires immediate medical treatment and hospitalization. If not treated it may be fatal. Allergies can affect anyone, but are more common in children than in adults. People suffering from asthma, or have family history of asthma or allergies are at higher risk of developing different types of allergies. About 50 million Americans suffer from allergic disease. According to World Allergy Organization, around 30-40% of the world’s population is affected with allergic conditions.

Treatment for allergy includes medicines, allergy shots, and avoiding the substances that causes the allergic reaction. Based on medicines, the anti-allergic therapeutic market is segmented into antihistamine (brompheniramine and cetirizine), corticosteroids (dexamethasone), mast cell stabilizers (cromolyn), decongestants (phenylephrine), and other medicine (Anti-IgE, Leukotriene). First generation antihistamine was discovered back in 1937 for the treatment of allergies. Owing to its sedative side effect, in the early 1990s, second generation antihistamine came into the picture for the treatment of allergies. Second generation antihistamine are mostly preferred because of their non-sedating nature. Corticosteroids first introduced in the 1970s possesses different mechanisms of action but does not repress release of histamine; hence, they are commonly preferred in combination with antihistamines. Patent expiration of leading prescription antihistamine and corticosteroid is leading to the introduction of more generic and OTC products in the anti-allergic therapeutic market. Allergy shots are also known as immunotherapy. Allergy shots segment is expected to expand in the anti-allergic therapeutic market because it is the only treatment that changes the immune system and prevents new allergies from developing. Introduction of newer forms of immunotherapy i.e. ‘sublingual immunotherapy’ also boosts the anti-allergic therapeutic market. For instance, in April 2017, the U.S FDA approved a house dust mite sublingual immunotherapy tablet for treatment of house dust mite-induced allergic rhinitis in adults. Rise in the patient pool suffering from different types of allergies is a major factor driving the market. Changes in lifestyle, increase in environmental pollution, growing demand for advance treatment, and changes in dietary habits have also propelled the anti-allergic therapeutic market. However, high cost of therapy and side effects are the factors restraining the anti-allergic therapeutics market.

In terms of geography, the anti-allergic therapeutics market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America and Europe dominated the anti-allergy therapeutics market due to rising percentage of population suffering from allergies. In addition, presence of developed health care infrastructure, rise in environmental pollution, and increasing demand for immunotherapy for treatment have accelerated the growth of the anti-allergy therapeutic markets in these regions. Asia Pacific is an emerging market due to the rising allergic patient population pool, rapid development of health care infrastructure, growing awareness about advance treatment options, and the increase in government expenditure in the health care sector. However, poor patient awareness, lack of proper treatment, and high cost of therapy restrains the growth of the anti-allergic therapeutics market in regions such as Middle East & Africa

Major players operating in the anti-allergic therapeutics market include Allergy Therapeutics, Allergan, Plc., Genentech, Inc., Collegium Pharmaceutical, Inc., McNeil Consumer Healthcare, Strides Arcolab, and Allergopharma GmbH & Co. KG.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Antiallergic Therapeutics Market

Pre Book